Sponsor content
218 result(s) found, displaying 21 to 30
-
Cancellation by sponsorRequested by CSL Behring (Australia) Pty Ltd
-
Australian Public Assessment Report (AusPAR)Andembry was approved for the prevention of recurrent hereditary angioedema (HAE) attacks in patients aged 12 years and older with C1-INH HAE (C1-esterase inhibitor deficiency or dysfunction).
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CSL Hong Kong Albumex 5 NexGen Human Albumin 50 g/L Solution for Intravenous Infusion.
-
Cancellation by sponsorRequested by CSL Behring (Australia) Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CSL United States of America Privigen normal immunoglobulin (human) (100g/L, 10%) solution for intravenous solution.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CSL New Zealand Fibrogammin Factor XIII, Freeze-Dried 1250 IU, powder forinjection vial with 20 mL diluent ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CSL Malaysia Intragam NexGen MY normal immunoglobulin (human) 5g 100 g/L, 10% solution for intravenous infusion.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CSL Malaysia Albumex 20 NexGen MY, Solution for infusion 20%.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CSL NZ Alburex 5 NZ human albumin 50 g/L (5% w/v) solution for intravenous infusion vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CSL Taiwan PRIVIGEN TW normal immunoglobulin (human) 5g (100g/L,10%) solution for intravenous infusion.